Fasken is delighted to be sponsoring and attending the Pharma & MedTech Compliance Conference, taking place on June 2-3, 2025, at the Omni King Edward Hotel in Toronto.
This annual event is the premier compliance and legal event for Canadian Pharma and MedTech professionals seeking updates from top industry thought leaders on regulatory developments and the latest strategies to navigate emerging risks.
Key Contributors
Fasken’s own Dara Jospé, Ingrid VanderElst, Jean-Raphaël Champagne and Mark Vanderveken will be key contributors to the program.
A team of Fasken lawyers including Timothy Squire, Mathieu Gagné, Robert Quesnel, and other members of Fasken’s legal team will also be on site during this event to connect with leading compliance professionals working exclusively within life science compliance and legal departments.
Understanding Guardrails for Pre-Launch Activities
Panel on Monday, June 2, 2025 | 4:45-5:30 PM
This panel will delve into defining acceptable engagement timelines, permissible promotional activities, and identifying eligible individuals for leading or attending initiatives such as Advisory Boards, Learning Programs, Disease State Discussions/Campaigns, and PSPs.
The discussion will explore common practical questions Pharma and MedTech face regarding pre-launch activities leading up to commercialization.
Speakers :
- Dara Jospé, Partner, Fasken
- Ingrid VanderElst, Partner, Fasken
- Anne Mayrand, Head, Legal Affairs & Compliance, Organon Canada
Key Compliance Considerations n Partnerships with Industry Stakeholders
Panel on Tuesday, June 3, 2025 | 11:35 AM-12:45 PM
This panel will examine strategies to develop robust compliance measures for establishing and managing successful partnerships with hospitals, universities, and research institutions. It will focus on ensuring the ethical engagement of healthcare professionals in research activities, navigating the complexities of donations and in-kind support to research institutions, mitigating risks through the separation of clinical and commercial functions, and prioritizing participation in ethical planning committees.
Speakers :
Jean-Raphaël Champagne, Partner, Fasken
Mark Vanderveken, Associate, Fasken
Register Now : https://informaconnect.com/pharmaceutical-compliance-congress-canada/purchase/select-package/
About Fasken's Life Sciences Team
Fasken's team provides comprehensive support to life sciences clients throughout their lifecycle. Whether you’re a biotech startup, entering clinical trials, scaling up, expanding to new markets or exploring exit strategies, our team speaks your language. We know the unique challenges biotech and pharma companies face in securing and enforcing your patent portfolio, bringing a product to market, complying with Canada’s regulations, or raising funds across a competitive landscape. We have knowledgeable practitioners with advanced degrees in pharmaceutical sciences, clinical pharmacology, toxicology, and genetics. We know the sector.
Fasken lawyers and agents collaborate with our clients to provide advice tailored to your needs including marketing and product labelling, IP drafting and enforcement, competition, tax, litigation, contracts and agreements and a full range of corporate services from financings to M&A. Navigate complex challenges and bring your products to market in Canada with a team dedicated to your success. With a strong legal network in 47 countries, we also continue to be at the forefront of life sciences advancement and interests globally.
Fasken is ranked Band 1 by Chambers for life sciences and is the most recognized Firm on The Globe & Mail’s list of Canada’s Best Law Firms 2025, including in every category of corporate law and in healthcare & life sciences and intellectual property.
For more information about Fasken's Life Sciences Group, please contact Lina A. Lafortune at llafortune@fasken.com.
